ProScribe’s latest R&D results were presented at the ISMPP Annual Meeting (USA; Apr 6-9, 2014).

In this patient-centric era, where industry trials in China are surging, ProScribe has completed the first study to focus specifically on what Chinese patients want from clinical trial results summaries.  Learn more about ProScribe and Envision Pharma Group here.